Inhaled nitric oxide and pulmonary embolism

[1]  F. Barale,et al.  Inhaled nitric oxide in patients with pulmonary embolism , 1998, Intensive Care Medicine.

[2]  M. Noc,et al.  Diagnosis and treatment of shock due to massive pulmonary embolism: approach with transesophageal echocardiography and intrapulmonary thrombolysis. , 1997, Chest.

[3]  J. Zijlstra,et al.  Oxygen desaturation after treatment with inhaled nitric oxide for obstructive shock due to massive pulmonary embolism. , 1997, Chest.

[4]  J. Barberà,et al.  Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.

[5]  M. Onoe,et al.  A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. , 1994, The Journal of thoracic and cardiovascular surgery.

[6]  D. Taggart,et al.  Endotoxemia, complement, and white blood cell activation in cardiac surgery: a randomized trial of laxatives and pulsatile perfusion. , 1994, The Annals of thoracic surgery.

[7]  P. Girard,et al.  Thrombolysis for life-threatening pulmonary embolism 2 days after lung resection. , 1993, The American review of respiratory disease.

[8]  P. Stein,et al.  A prospective investigation of pulmonary embolism in women and men. , 1992, JAMA.

[9]  A. Alavi,et al.  The clinical course of pulmonary embolism. , 1992, The New England journal of medicine.

[10]  M. Fox,et al.  Selective decontamination of the digestive tract in cardiac surgical patients , 1991, Critical care medicine.

[11]  J. Widimský.  Acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: is there a relationship? , 1991, The European respiratory journal.

[12]  Y. Castaing,et al.  Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. , 1986, The American review of respiratory disease.

[13]  L. Slykerman,et al.  Effects of hydralazine and nitroprusside on cardiopulmonary function when a decrease in cardiac output complicates a short-term increase in pulmonary vascular resistance. , 1983, Circulation.

[14]  B. Massie,et al.  Deleterious effects of hydralazine in patients with pulmonary hypertension. , 1982, The New England journal of medicine.

[15]  B. Pitt,et al.  Oral hydralazine therapy for acute pulmonary embolism and low output state. , 1981, Archives of internal medicine.

[16]  J. Takala,et al.  Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass--role of type of flow and protective effect of selective digestive decontamination. , 1998, Intensive care medicine.

[17]  C. Stoutenbeek,et al.  Significant Reduction of Faecal Endotoxin Pool by Oral Polymyxin E and Tobramycin in Human Volunteers , 1989 .